Jésus Aguilar

ORCID: 0000-0003-2502-6752
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoidosis and Beryllium Toxicity Research
  • Pain Management and Placebo Effect
  • Fungal Infections and Studies
  • S100 Proteins and Annexins
  • Migraine and Headache Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Eosinophilic Disorders and Syndromes
  • Neurological disorders and treatments
  • CAR-T cell therapy research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Moyamoya disease diagnosis and treatment
  • Pain Mechanisms and Treatments
  • Neurological Complications and Syndromes

Centre Hospitalier Universitaire de Nantes
2025

Nantes Université
2022-2025

Abstract Introduction Neurosarcoidosis (NS) is a systemic inflammatory granulomatous disease affecting of patients with sarcoidosis. Its diagnosis difficult as there no specific test for it. Because its rarity, the management NS has so far only been described in case series and short retrospective cohorts. The objective this study description clinical, paraclinical presentation therapeutic central nervous system (CNS) involvement France. Methods This multicenter, retrospective, observational...

10.1002/brb3.3443 article EN cc-by Brain and Behavior 2024-09-01

Pain is a frequent and disabling non-motor symptom of Parkinson's Disease (PD). Yet, no treatment to date can efficiently reduce this pain. This article investigates the brain functional connectivity PD patients with central pain effects levodopa oxycodone on connectivity. Thirty-eight received either levodopa, oxycodone, or placebo during an eight-week period. intensity was evaluated using Visual Analogue Scale resting-state measured before after treatments. were also separated into two...

10.1016/j.ynirp.2024.100197 article EN cc-by-nc-nd Neuroimage Reports 2024-02-02

Abstract Immune effector cell‐associated neurotoxicity syndrome (ICANS) is a frequent adverse event after Chimeric antigen receptor T cells (CAR‐T cells). A patient treated with anti‐CD19 CAR‐T for refractory mantle cell lymphoma presented at Day 8 post‐infusion extensive myelitis. Unusual eosinophilia was disclosed in the patient's cerebrospinal fluid. After treatment methylprednisolone and siltuximab, decrease clinical symptoms magnetic resonance imaging lesions were obtained. This...

10.1002/jha2.381 article EN cc-by eJHaem 2022-02-01
Coming Soon ...